MoneyWorks4Me

Granules India informs about clarification

23 Mar 2024 Evaluate
Granules India has informed that the Company has received a copy of the reports from the proxy firms which it has released as a voting advisory to the institutional investors on the resolutions proposed by the Company in the Postal Ballot Notice dated 19.02.2024 which was disseminated to the Members of the Company on 29.02.2024. On review of the said reports, it enclosed clarification on the special resolution proposed for the appointment of Priyanka Chigurupati (DIN:01793431) as a Whole-time Director of the Company for a term of 5 (five) years.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1851.85
Dr. Reddys Labs. 1194.95
Cipla 1378.80
Lupin 2093.75
Zydus Lifesciences 1157.00
View more..